oxazolidin-2-one has been researched along with thioacetazone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Lahoz, JM; Laguna, F; Moreno, V; Valencia, ME | 1 |
| Ahuja, S; Benedetti, A; Cox, H; Fox, GJ; Koh, WJ; Menzies, D; Pasvol, G; Viiklepp, P | 1 |
1 review(s) available for oxazolidin-2-one and thioacetazone
| Article | Year |
|---|---|
Group 5 drugs for multidrug-resistant tuberculosis: individual patient data meta-analysis.
Topics: Adult; Amoxicillin; Antitubercular Agents; Clofazimine; Cohort Studies; Drug Therapy, Combination; Female; Humans; Isoxazoles; Linezolid; Logistic Models; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Oxazolidinones; Thioacetazone; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
1 other study(ies) available for oxazolidin-2-one and thioacetazone
| Article | Year |
|---|---|
[Multiresistant tuberculosis caused by Mycobacterium bovis and human immunodeficiency virus infection. Are there new therapeutic possibilities?].
Topics: Acetamides; Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Clavulanic Acid; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Isoniazid; Linezolid; Mycobacterium bovis; Oxazolidinones; Thioacetazone; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |